LS Investment Advisors LLC Reduces Position in Agilent Technologies Inc (A)

LS Investment Advisors LLC cut its holdings in shares of Agilent Technologies Inc (NYSE:A) by 6.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,376 shares of the medical research company’s stock after selling 472 shares during the period. LS Investment Advisors LLC’s holdings in Agilent Technologies were worth $513,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of A. Kentucky Retirement Systems purchased a new position in shares of Agilent Technologies during the 3rd quarter valued at $1,562,000. Neuberger Berman Group LLC raised its position in shares of Agilent Technologies by 1,029.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 242,432 shares of the medical research company’s stock worth $17,101,000 after buying an additional 220,966 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Agilent Technologies by 17.7% during the 3rd quarter. Nordea Investment Management AB now owns 18,394 shares of the medical research company’s stock worth $1,298,000 after buying an additional 2,760 shares in the last quarter. Legal & General Group Plc raised its position in shares of Agilent Technologies by 8.8% during the 3rd quarter. Legal & General Group Plc now owns 1,712,847 shares of the medical research company’s stock worth $120,832,000 after buying an additional 138,944 shares in the last quarter. Finally, Vanguard Group Inc raised its position in shares of Agilent Technologies by 0.8% during the 3rd quarter. Vanguard Group Inc now owns 24,155,483 shares of the medical research company’s stock worth $1,703,929,000 after buying an additional 194,607 shares in the last quarter.

Shares of Agilent Technologies stock traded up $0.66 during trading on Friday, hitting $68.36. The stock had a trading volume of 3,802,263 shares, compared to its average volume of 2,195,875. The company has a market cap of $22.01 billion, a P/E ratio of 24.50, a price-to-earnings-growth ratio of 1.90 and a beta of 1.33. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.82. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $82.27.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing the consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The business’s revenue was up 2.7% on a year-over-year basis. During the same period last year, the business earned $0.65 earnings per share. On average, analysts expect that Agilent Technologies Inc will post 3.05 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be given a $0.164 dividend. This represents a $0.66 annualized dividend and a dividend yield of 0.96%. The ex-dividend date is Monday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.66%.

A number of analysts have commented on A shares. UBS Group started coverage on shares of Agilent Technologies in a research report on Friday, March 15th. They set a “buy” rating and a $92.00 price target on the stock. Deutsche Bank boosted their price target on shares of Agilent Technologies from $80.00 to $85.00 and gave the stock a “buy” rating in a research report on Tuesday, February 12th. Cowen lifted their price objective on shares of Agilent Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 26th. JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, February 21st. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price objective (up previously from $77.00) on shares of Agilent Technologies in a research note on Monday, February 25th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and an average price target of $86.58.

In related news, Director Paul N. Clark sold 2,823 shares of the firm’s stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $80.31, for a total transaction of $226,715.13. Following the completion of the sale, the director now directly owns 88,857 shares in the company, valued at $7,136,105.67. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Michael Tang sold 6,728 shares of the firm’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $80.50, for a total transaction of $541,604.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,162 shares of company stock worth $2,575,907.

TRADEMARK VIOLATION NOTICE: This article was first published by Sundance Herald and is owned by of Sundance Herald. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://sundanceherald.com/2019/05/24/ls-investment-advisors-llc-has-513000-position-in-agilent-technologies-inc-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Federal Reserve

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply